Protocol Registration

All trials conducted at the Centre of Evidence Based Dermatology (CEBD) are registered on an approved trial registry prior to start of recruitment. These can be accessed using the World Health Organisation’s (WHO) International Clinical Trials Registry Platform. Similarly, systematic review protocols are lodged on the Prospero register of systematic review.

In addition, CEBD pre-registers study protocols and analysis plans for studies that do not fit the criteria for existing registries.

Table of Protocols
Title	Date registered
A qualitative study to determine the health care professionals’ experience of the diagnosis of lower limb cellulitis	9 May 2019
Mapping of Diagnostic Criteria in Dermatology	30 April 2019
DIPSOC Statistical Analysis Plan	25 February 2019
Uptake of HOME core outcomes; study of trial registries	3 December 2018
A qualitative study to determine the patient experience of the diagnosis of lower limb cellulitis	5 November 2018
Exploring the optimum number of repeated measures of disease severity in eczema clinical trials.	1 November 2018
Developing a patient-reported outcome measure of eczema control Protocol Data Analysis Plan - vs 1.2 (previous version: vs1.0, vs1.1)	Protocol: 27 September 2018 Data analysis plan: 6 November 2018
Protocol for retrospective study assessing the relationship between serum Vitamin D levels and severity of malignant melanoma	27 November 2017
Scoping review of the challenges identified by patients and health care professionals when diagnosing lower limb cellulitis protocol	19 October 2017
Protocol for a 10-year review of surgical management of Dermatofibrosarcoma Protuberans (DFSP) in the UK	25 August 2017
Which outcomes should we measure in cellulitis trials? Results of a systematic review of outcomes included in cellulitis trials and a patient priority setting survey	25 August 2017
Exploring how patient characteristics influence the minimum important change (MIC) of the Patient Oriented Eczema Measure (POEM)	03 August 2017
Patient involvement in the HOME V meeting – understanding it from the patient perspective	03 August 2017
Patient and carer perspectives on defining and measuring long-term control of eczema	25 April 2017
Exploring different methods to inform Minimally Important Change (MIC) estimates of the Patient Oriented Eczema Measure (POEM) using data from the CLOTHES trial	05 January 2017
Protocol for e-Delphi consensus study to agree diagnostic criteria for plaque psoriasis in children	20 June 2016
Protocol for determining the association between sample size and risk of bias in dermatological randomised controlled trials	18 December 2015
Protocol for identifying parallel group RCTs within the Global Resource for EczemA Trials (GREAT) database that failed to compare the treatments being tested	24 February 2015
Systematic review on quality of life measures in eczema trials	9 January 2015
How has long term control been captured in randomised controlled trials of eczema treatments? A systematic review protocol	6 October 2014
How are eczema symptoms captured in randomised controlled trials of eczema treatments? A systematic review protocol	23 July 2014
Protocol registration and outcome reporting bias in randomised controlled trials of eczema treatment	25 August 2011
A Randomised Controlled Trial of Excisional Surgery versus Imiquimod 5% cream for Nodular and Superficial Basal Cell Carcinoma (SINS) Final Analysis Plan	24 June 2011
Identifying and prioritising important research questions for the treatment of eczema – a collaborative partnership between patients, carers, clinicians and researchers	21 April 2010
Identifying and prioritising important research questions for the treatment of vitiligo	15 November 2009

Protocol Registration

Centre of Evidence Based Dermatology

Legal information

Get social